This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ip, C. Articles by Shea-Eaton, W. Search for Related Content PubMed PubMed Citation Articles by Ip, C. Articles by Shea-Eaton, W.

Induction of Apoptosis by Conjugated Linoleic Acid in Cultured Mammary Tumor Cells and Premalignant Lesions of the Rat Mammary Gland¹

Departments of Experimental Pathology [C. I., T. L.] and Pharmacology and Therapeutics [M. M. I., S. S., W. S-E.], Roswell Park Cancer Institute, Buffalo, New York 14263

Conjugated linoleic acid (CLA) is an effective agent in preventing mammary cancer in rats treated with a carcinogen. The appearance of a tumor mass is the net result of cell proliferation minus cell death. Thus, apoptosis could be an important mechanism in controlling clonal expansion of the early premalignant lesions. The overall objective of this report was to determine whether CLA stimulated apoptosis. In the first part of the study, CLA was found to increase chromatin condensation (visualized through fluorescent 4',6-diamidino-2-phenylindole staining to DNA) and to induce DNA laddering, both evidence of apoptosis, in a rat mammary tumor cell line. The second part was to investigate the effect of CLA feeding on the development of histologically identifiable premalignant lesions in the rat mammary gland, as well as on the quantification of apoptosis (by terminal uridyltransferase nick end labeling assay) and the expression by immunohistochemistry of apoptosis regulatory proteins (bcl-2, bak, and bax) in normal versus premalignant mammary structures. CLA inhibited the formation of premalignant lesions by 50%. It also significantly increased apoptosis and reduced the expression of bcl-2 in these lesions, but it did not modulate the levels of bak or bax. In contrast, neither apoptosis nor any of the apoptosis regulatory proteins was affected by CLA in normal mammary gland alveoli or terminal end buds. The data suggest that early pathological lesions may be particularly sensitive to CLA. In addition to providing a molecular basis for elucidating the mechanism of action of CLA in cancer prevention, the research on CLA-responsive biomarkers also has a practical side because these assays can be applied to biopsied human tissue samples in future CLA intervention trials.

This article has been cited by other articles:

				L. Ou, Y. Wu, C. Ip, X. Meng, Y.-C. Hsu, and M. M. Ip Apoptosis induced by t10,c12-conjugated linoleic acid is mediated by an atypical endoplasmic reticulum stress response J. Lipid Res., May 1, 2008; 49(5): 985 - 994. [Abstract] [Full Text] [PDF]

				X. Meng, S. F. Shoemaker, S. O. McGee, and M. M. Ip t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways Carcinogenesis, May 1, 2008; 29(5): 1013 - 1021. [Abstract] [Full Text] [PDF]

				E. Rosberg-Cody, M. C. Johnson, G. F. Fitzgerald, P. R. Ross, and C. Stanton Heterologous expression of linoleic acid isomerase from Propionibacterium acnes and anti-proliferative activity of recombinant trans-10, cis-12 conjugated linoleic acid Microbiology, August 1, 2007; 153(8): 2483 - 2490. [Abstract] [Full Text] [PDF]

				M. M. Ip, S. O. McGee, P. A. Masso-Welch, C. Ip, X. Meng, L. Ou, and S. F. Shoemaker The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium Carcinogenesis, June 1, 2007; 28(6): 1269 - 1276. [Abstract] [Full Text] [PDF]

				A. L. Lock, B. A. Corl, D. M. Barbano, D. E. Bauman, and C. Ip The Anticarcinogenic Effect of trans-11 18:1 Is Dependent on Its Conversion to cis-9, trans-11 CLA by {Delta}9-Desaturase in Rats J. Nutr., October 1, 2004; 134(10): 2698 - 2704. [Abstract] [Full Text] [PDF]

				P. G Moorman and P. D Terry Consumption of dairy products and the risk of breast cancer: a review of the literature Am. J. Clinical Nutrition, July 1, 2004; 80(1): 5 - 14. [Abstract] [Full Text] [PDF]

				C. J Field and P. D Schley Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1190S - 1198S. [Abstract] [Full Text] [PDF]

				M. Q. Kemp, B. D. Jeffy, and D. F. Romagnolo Conjugated Linoleic Acid Inhibits Cell Proliferation through a p53-Dependent Mechanism: Effects on the Expression of G1-Restriction Points in Breast and Colon Cancer Cells J. Nutr., November 1, 2003; 133(11): 3670 - 3677. [Abstract] [Full Text] [PDF]

				J. M. Brown and M. K. McIntosh Conjugated Linoleic Acid in Humans: Regulation of Adiposity and Insulin Sensitivity J. Nutr., October 1, 2003; 133(10): 3041 - 3046. [Abstract] [Full Text] [PDF]

				B. A. Corl, D. M. Barbano, D. E. Bauman, and C. Ip cis-9, trans-11 CLA Derived Endogenously from trans-11 18:1 Reduces Cancer Risk in Rats J. Nutr., September 1, 2003; 133(9): 2893 - 2900. [Abstract] [Full Text] [PDF]

				M. A. Belury Inhibition of Carcinogenesis by Conjugated Linoleic Acid: Potential Mechanisms of Action J. Nutr., October 1, 2002; 132(10): 2995 - 2998. [Abstract] [Full Text] [PDF]

				E. J. Kim, P. E. Holthuizen, H. S. Park, Y. L. Ha, K. C. Jung, and J. H. Y. Park Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G357 - G367. [Abstract] [Full Text] [PDF]

				J. M. Brown, Y. D. Halvorsen, Y. R. Lea-Currie, C. Geigerman, and M. McIntosh Trans-10, Cis-12, But Not Cis-9, Trans-11, Conjugated Linoleic Acid Attenuates Lipogenesis in Primary Cultures of Stromal Vascular Cells from Human Adipose Tissue J. Nutr., September 1, 2001; 131(9): 2316 - 2321. [Abstract] [Full Text] [PDF]